Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,600 | 403 | 99.0% |
| Education | $74.25 | 3 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,005 | 56 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,001 | 55 | $0 (2024) |
| ABBVIE INC. | $931.82 | 60 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $591.99 | 36 | $0 (2024) |
| Janssen Biotech, Inc. | $576.08 | 33 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $351.81 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $338.18 | 14 | $0 (2024) |
| GENZYME CORPORATION | $332.07 | 15 | $0 (2024) |
| EVOKE PHARMA, INC. | $331.44 | 17 | $0 (2024) |
| Gilead Sciences, Inc. | $318.36 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,331 | 104 | Phathom Pharmaceuticals, Inc. ($351.81) |
| 2023 | $1,741 | 90 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($385.92) |
| 2022 | $1,830 | 109 | Takeda Pharmaceuticals U.S.A., Inc. ($303.26) |
| 2021 | $1,772 | 103 | AbbVie Inc. ($455.76) |
All Payment Transactions
406 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Immunology | ||||||
| 12/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $29.81 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/04/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Immunology | ||||||
| 11/26/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $23.72 | General |
| Category: GI | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.68 | General |
| 11/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.57 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Immunology | ||||||
| 10/09/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.38 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 177 | 206 | $79,361 | $15,683 |
| 2022 | 3 | 146 | 160 | $63,215 | $12,523 |
| 2021 | 3 | 137 | 150 | $58,516 | $12,075 |
| 2020 | 3 | 98 | 103 | $21,638 | $6,301 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 124 | $43,152 | $8,837 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $29,810 | $5,481 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 27 | $6,399 | $1,364 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 85 | $29,580 | $6,398 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $28,184 | $5,037 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 23 | $5,451 | $1,089 | 20.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 86 | $29,928 | $6,720 | 22.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $23,848 | $4,432 | 18.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 20 | $4,740 | $923.68 | 19.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 30 | 30 | $8,920 | $2,946 | 33.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 38 | $8,797 | $1,859 | 21.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 35 | $3,921 | $1,497 | 38.2% |
About Amanda Davis, CRNP
Amanda Davis, CRNP is a Family healthcare provider based in Helena, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2017. The National Provider Identifier (NPI) number assigned to this provider is 1619413275.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Davis, CRNP has received a total of $7,674 in payments from pharmaceutical and medical device companies, with $2,331 received in 2024. These payments were reported across 406 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,600).
As a Medicare-enrolled provider, Davis has provided services to 558 Medicare beneficiaries, totaling 619 services with total Medicare billing of $46,582. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Helena, AL
- Active Since 01/06/2017
- Last Updated 07/21/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619413275
Products in Payments
- ENTYVIO (Biological) $905.61
- DUPIXENT (Biological) $670.25
- Linzess (Drug) $591.99
- XIFAXAN (Drug) $568.24
- STELARA (Biological) $535.22
- LINZESS (Drug) $456.85
- TRULANCE (Drug) $436.76
- VOQUEZNA (Drug) $351.81
- GIMOTI (Drug) $331.44
- IBSRELA (Drug) $309.34
- CREON (Drug) $227.02
- DIFICID (Drug) $211.14
- SUCRAID (Drug) $207.16
- MAVYRET (Drug) $190.00
- ZEPOSIA (Drug) $181.95
- XELJANZ (Drug) $138.77
- ZENPEP (Drug) $96.06
- Talicia (Drug) $69.12
- MOTEGRITY (Drug) $66.75
- VIBERZI (Drug) $57.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Helena
Dr. Jessica Havens, Dnp, DNP
Family — Payments: $11,215
Nolan Bauldree, Crnp, CRNP
Family — Payments: $3,701
Christopher Vanhorssen, Dnp, Aprn, Bsn, Rn, DNP, APRN, BSN, RN
Family — Payments: $2,246
Jeannie Fahlquist, Np-C, NP-C
Family — Payments: $2,033
Mary Middagh, N.p, N.P
Family — Payments: $1,760
Ms. Julie Flesch, Aprn, APRN
Family — Payments: $1,691